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The amino acid sequence of the UL31 protein (UL31P) of equine herpesvirus 1 (EHV-1) has homology to
that of the ICP8 of herpes simplex virus type 1 (HSV-1). Here we show that the UL31 gene is
synergistically trans-activated by the IEP and the UL5P (EICP27). Detection of the UL31 RNA transcript
and the UL31P in EHV-1-infected cells at 6 h post-infection (hpi) as well as metabolic inhibition assays
indicated that UL31 is an early gene. The UL31P preferentially bound to single-stranded DNA over
double-stranded DNA in gel shift assays. Subcellular localization of the green ﬂuorescent protein (GFP)–
UL31 fusion proteins revealed that the C-terminal 32 amino acid residues of the UL31P are responsible
for the nuclear localization. These ﬁndings may contribute to deﬁning the role of the UL31P single-
stranded DNA-binding protein in EHV-1 DNA replication.
& 2012 Elsevier Inc. All rights reserved.Introduction
Equine herpesvirus 1 (EHV-1) is a member of the Alphaher-
pesvirinae subfamily along with varicella-zoster virus (VZV),
pseudorabies virus (PRV), bovine herpesvirus 1 (BHV-1), and
herpes simplex virus type 1 (HSV-1) (Roizman and Pellet, 2001).
As a major pathogen of horses, EHV-1 causes respiratory disease,
neurological disorders, and abortion in pregnant mares (Allen and
Bryans, 1986; Crabb and Studdert, 1995; O’Callaghan and
Osterrieder, 2008). During a lytic infection, EHV-1 gene expres-
sion is controlled by viral negative and positive regulatory
molecules and is divided into immediate-early (IE), early, and
late stages (Ahn et al., 2007, 2010, 2011; Caughman et al., 1985;
Charvat et al., 2011; Gray et al., 1987a, 1987b; Holden et al., 1995;
Kim et al., 1997, 1999, 2006, 2011; Smith et al., 1992; Zhao et al.,
1995). The sole IE gene is expressed ﬁrst followed by expression
of early genes, and then late genes are turned on after viral DNA
replication (O’Callaghan and Osterrieder, 2008).
Extensive studies of HSV-1 DNA replication showed that seven
viral proteins are essential for HSV-1 DNA replication (Challberg,
1986; Conley et al., 1981; Gao et al., 1993): a HSV-1 single-strandedll rights reserved.
obiology and Immunology,
501 Kings Highway, P.O.Box
5 5764.DNA-binding protein (ICP8), a DNA polymerase (UL30P), a DNA
polymerase accessory protein (UL42P), an origin-binding protein
(UL9P), and a helicase-primase complex (UL5P, UL8P, and UL52P).
Among the seven DNA replication-associated proteins, the roles of
single-stranded DNA-binding protein are quite interesting. HSV-1
ICP8 has multi-functions in viral DNA replication. It preferentially
binds to single-stranded DNA (Gourves et al., 2000; Lee and Knipe,
1985; Ruyechan, 1983, 1988), mediates strand exchange, inhibits
single-stranded DNA digestion, and stimulates double-stranded DNA
digestion (Boehmer and Lehman, 1993; Bortner et al., 1993; Dutch
and Lehman, 1993; Reuven andWeller, 2005). Furthermore, ICP8 has
been reported to modulate the activity of the viral polymerase
(UL30P) (Chiou et al., 1985; Hernandez and Lehman, 1990;
O’Donnell et al., 1987) and to promote the helicase activity of the
viral helicase-primase complex (UL5P/UL8P/UL52P) (Falkenberg
et al., 1998; Hamatake et al., 1997). It has been proposed that the
C-terminal a-helix is required for the localization of ICP8 to
prereplicative sites by binding to viral or cellular factors that target
or retain ICP8 at speciﬁc intranuclear sites (Taylor and Knipe, 2003).
The VZV counterpart of single-stranded DNA-binding protein is
encoded by VZV open reading frame (ORF) 29 and is expressed in
human ganglia during latency (Kinchington et al., 1988; Lungu et al.,
1998; Roberts et al., 1985). It appears in the nucleus during lytic
infection but in the cytoplasm of infected neurons during latency
(Lungu et al., 1998). In addition, ORF29P inﬂuences expression of
some viral genes that are regulated by an IE ORF62 protein (ORF62P)
(Boucaud et al., 1998; Cohen et al., 2007).
S. Kim et al. / Virology 432 (2012) 306–315 307It has been previously demonstrated that the putative catalytic
subunit (pORF30) and accessory protein (pORF18) of EHV-1 DNA
polymerase are the counterparts of HSV-1 UL30 and UL42,
respectively (Allen et al., 1977; Loregian et al., 2006). Activity of
ORF30P as a DNA polymerase is stimulated by the ORF18P as an
accessory subunit of the viral DNA polymerase. The amino acid
sequence of EHV-1 UL31P (previously designated as ICP130)
revealed its homology with HSV-1 ICP8 and VZV ORF29P, sug-
gesting that the UL31P may have similar properties of HSV-1 ICP8
or VZV ORF29P in EHV-1 DNA replication. A previous study
reported that EHV-1 UL31 nuclear protein bound to both single-
and double-stranded DNA when using nuclear cell extracts of
EHV-1 infected RK13 cells in gel shift assays (Lewis et al., 1995).
However, it is still unknown how UL31 gene is regulated, at which
stage the UL31 gene is expressed, which region of the UL31P is
responsible for its nuclear localization, and whether UL31P
harbors the independent capability to bind to both single- and
double-stranded DNAs. In this study, we showed that the EHV-1
UL31 gene is synergistically trans-activated by the IEP and the
UL5P (EICP27). Metabolic inhibition assays revealed that UL31 is
an early gene. Moreover, the UL31P harbors a nuclear localization
signal sequence at the extreme 32 residues of the C-terminus and
preferentially binds to single-stranded DNA over double-stranded
DNA in gel shift assays.+1
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UL31 gene trans-activated by the IEP encodes 120 kDa UL31
protein
The UL31 ORF located within the EHV-1 UL genomic region
encodes a UL31 protein (UL31P) of 1209 amino acids (Fig. 1A)
(Telford et al., 1992). The UL31 gene of EHV-1 RacL11 strain was
PCR-ampliﬁed, cloned, and then sequenced (Kim et al., unpub-
lished data). Comparisons of the DNA sequences of the Ab4p andM
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Fig. 1. Location of UL31 gene in EHV-1 genome and detection of UL31 protein.
(A) Location of UL31 gene in EHV-1 genome. Gene location was based on
previously published Ab4 EHV-1 sequence (Telford et al., 1992). (B) Detection of
UL31P from RK13 cells infected with EHV-1 and transfected with plasmid
expressing UL31P or GFP–UL31P.RacL11 UL31 genes showed seven nucleotide differences (99.8%
identity) that resulted in three amino acid differences (99.8%
identity). In order to perform functional studies, we cloned and
expressed UL31P in RK13 cells as an intact protein as well as a
recombinant green ﬂuorescent protein (GFP) fusion protein. An
120 kDa UL31P was detected in RK13 cells infected with EHV-1
(Fig. 1B, lane 3) or transfected with the plasmid expressing the
UL31 ORF (Fig. 1B, lane 4), but not in mock-infected cells (Fig. 1B,
lane 2). Moreover, anti-UL31P monoclonal antibody YC3 was also
able to detect an 147 kDa GFP–UL31P fusion protein in cells
transfected with the pEGFP-UL31 plasmid (Fig. 1B, lane 5), but not
with the pEGFP-N1 control plasmid (Fig. 1B, lane 6). These
ﬁndings indicated that the UL31 gene is expressed as an
120 kDa protein. Next, luciferase reporter assays were per-
formed to examine how the UL31 gene is regulated. As shown
in Fig. 2, the different regions of the UL31 ORF upstream sequence
were cloned into the pGL3-basic plasmid [pUL31(–1423/–3)-Luc,
pUL31(–1423/–143)-Luc, pUL31(–1423/–265)-Luc, pUL31(–1033/
–143)-Luc, and pUL31(–1033/–3)-Luc]. Reporter plasmids were
co-transfected into RK13 cells without effector plasmids, and
promoter activities were determined. The maximal luciferase
activity was shown from pUL31(–1033/–3)-Luc (Fig. 2B, bar 5)
so that this plasmid was used for following luciferase assays.
Interestingly, pUL31(–1423/–265)-Luc lacking a tentative TATA
box sequences [UL31(–232/–227)] showed very low promoter
activity (Fig. 2B, bar 3), suggesting that a TATA box sequence
(TATAAT) is required for full activation of the UL31 gene. To
determine which EHV-1 regulatory protein trans-activates thepUL31(-1423/-143)-Luc
pUL31(-1423/-265)-Luc
pUL31(-1033/-143)-Luc
pUL31(-1033/-3)-Luc
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Fig. 2. UL31 promoter region cloned into luciferase reporter vector and UL31
promoter activity. (A) The UL31 promoter region cloned into luciferase reporter
vector. The number indicates nucleotide distance from UL31 ORF ﬁrst nucleotide
(þ1). The tentative TATA box sequence is located on UL31(232/227). Different
regions of UL31 promoter were cloned into luciferase reporter vector as described
in Materials and methods. (B) The UL31 promoter activities were examined
without effector plasmid as described in Materials and methods. Promoter activity
is expressed as relative luciferase units (RLU). Each experiment was carried out in
triplicate. Error bars represent the mean7standard deviation (SD) of three
independent experiments.
S. Kim et al. / Virology 432 (2012) 306–315308UL31 gene, further promoter assays were performed using
pUL31(–1033/–3)-Luc and effector vectors expressing each of
the EHV-1 regulatory proteins. The UL31 gene was trans-activated
by the IEP, but not independently by any other EHV-1 regulatory
protein (Fig. 3A). Further, additional assays revealed that the IEP
synergistically trans-activates the UL31 gene with the UL5P, a
homolog of HSV-1 ICP27 (Fig. 3B), whereas IR2P, a negative EHV-1
regulatory molecule (Kim et al., 2006, 2011), interfered with
trans-activation of the IEP (Fig. 3B).
UL31 is an early gene
Next, to determine in which stage of the EHV-1 replication
cycle the UL31 gene is expressed, the synthesis of the UL31
transcript and UL31 protein was examined at various times after
infection. The UL31 transcript was not detected at the immediate-
early time of either 1 or 3 h post-infection (hpi; Fig. 4A, lanes
2 and 3, respectively) or in mock-infected cells (Fig. 4A, lane 1),
but was ﬁrst detected at 6 hpi and increased signiﬁcantly in
amount at late times of infection at 8 and 12 hpi (Fig. 4A, lanes
5 and 6, respectively). Similarly, the UL31 protein was ﬁrst
detected in small amounts at 6 hpi and was produced in large
amounts at 12 hpi (Fig. 4B, lanes 4 and 5, respectively). These
ﬁndings suggested that UL31 is an early gene. To conﬁrm the
assignment of UL31 as a member of the early class, assays
employing metabolic inhibitors were performed by using cyclo-
heximide (CHX) to block protein synthesis and phosphonoacetic
acid (PAA) to inhibit EHV-1 DNA synthesis. The EHV-1 IE, early
thymidine kinase (TK), and late glycoprotein K (gK) genes were
used as positive controls. As expected, the IE transcript was
expressed in uninhibited and CHX-treated infected RK13 cells
(Fig. 4C, IE lanes 2 and 3, respectively). The TK transcript was0
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Fig. 3. The trans-activation of the UL31 promoter by a single or double effector vectors
pCMV-IR4 (EICP22), pSVEICP0, pSVUL5 (EICP27), pCMV-ETIF, and pCMV-UL31) were
mean7SD. (A) UL31 promoter activity by a single effector plasmid. (B) UL31 promotedetected in both uninhibited cells and in PAA-treated cells
(Fig. 4C, TK, lanes 2, 4, and 5, respectively) but not in CHX-treated
cells even at 6 hpi (Fig. 4C, TK, lane 3) as expected for a gene of the
early class. Expression of the gK transcript was not detected at
6 hpi in either uninhibited or CHX-treated infected cells (Fig. 4C,
gK, lanes 2 and 3, respectively) and also was not detected at
20 hpi in PAA-treated cells (Fig. 4C, gK, lane 5), conﬁrming that gK
is a true late gene as its transcription requires the initiation of
viral DNA synthesis. In the case of the UL31 gene, the results were
identical to those of the TK gene in that synthesis of the UL31
transcript was readily detected at 6 hpi in uninhibited infected
cells and at 20 hpi in PAA-treated cells (Fig. 4C, UL31 lanes 2 and
5, respectively), but was inhibited in CHX-treated cells. Thus, the
results of all experiments in Fig. 4 clearly demonstrate that EHV-1
UL31 is an early gene.
UL31P binds to a single-stranded DNA in a sequence-independent
manner
According to previous studies (Lewis et al., 1995), the UL31P
(previously designated ICP130) in nuclear extracts obtained from
EHV-1-infected RK13 cells bound to both single- and double-
stranded DNAs. However, the amino acid sequence homology of
UL31P to the HSV-1 single-stranded DNA binding protein (ICP8)
suggests the possibility that the UL31P may have a binding
speciﬁcity to single-stranded DNA and that the UL31P indirectly
binds to double-stranded DNA by nuclear cell extracts obtained
from EHV-1-infected cells. To examine this possibility, we pur-
iﬁed full-length UL31P as a glutathione S-transferase (GST)-UL31P
fusion protein and employed it in DNA-binding assays with a
radiolabeled single- and double-stranded DNA probe as described
in Materials and methods. Puriﬁed GST-UL31 fusion proteinEI
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Fig. 4. Detection of the UL31 transcript and the UL31P. Western blot and northern
blot analysis were performed as described in Materials and methods. (A) Detection
of the UL31 transcript from EHV-1-infected RK13 cells at indicated time points.
(B) Detection of the UL31P from EHV-1-infected RK13 cells at different time
points. Western blot was performed using an anti-UL31 monoclonal antibody YC3
(1:1,000) and an anti-b-actin monoclonal antibody (1:5,000) as an internal
control. (C) Detection of EHV-1 representative gene and UL31 gene transcripts
from EHV-1-infected RK13 cells in the presence of protein synthesis inhibitor CHX
or viral DNA synthesis inhibitor PAA.
S. Kim et al. / Virology 432 (2012) 306–315 309(150 kDa) was detected by western blot using an anti-UL31P
monoclonal antibody (Fig. 5A, lane 3). The puriﬁed GST-UL31P
bound to single-stranded DNA probes and yielded a pattern with
multiple bands (Fig. 5B, lanes 3 and 8), but not to double-stranded
DNA (Fig. 5B, lane 13), whereas GST protein did not bind to either
a single-stranded or double-stranded DNA (Fig. 5B, lanes 2, 7, and
12). Moreover, the addition of anti-UL31P monoclonal antibody
YC3 led to a supershift of the single-stranded DNA probe (Fig. 5B,
lanes 4 and 9). However, the DNA-protein complex was not
supershifted by the addition of EHV-1 IE region 2-speciﬁc mono-
clonal antibody E1.1 (Fig. 5B, lanes 5 and 10). These results
indicate that the UL31P binds to a single-stranded DNA.
To determine whether the interaction of UL31P with a single-
stranded DNA is sequence-speciﬁc, three different sequence DNA
probes were employed in gel shift assays: a 46-mer oligonulceo-
tide corresponding to nucleotides (nt) -18 to -63 of the EHV-1 IE
gene promoter (Fig. 5C, lanes 1-4), a 60-mer spanning the EHV-1
early TK gene promoter (positions 290 to 349 nt relative to
the translational start codon of TK ORF; Fig. 5C, lanes 5-8), and a
60-mer spanning the simian virus 40 (SV40) early promoter
(positions -10 to -69 nt relative to the transcription start site;
Fig. 5C, lanes 9–12). The GST-UL31P was able to bind to all three
single-stranded DNA probes with multiple bands (Fig. 5C, lanes 3,
7, and 11), suggesting that the DNA-binding ability of the UL31P is
not dependent on DNA sequence. The presence of multiple bands
in gel shift assays may be due to the cooperative binding of the
UL31P to single-stranded DNA as shown in binding of HSV-1 ICP8(EHV-1 UL31P homolog) to single-stranded DNA (Dudas and
Ruyechan, 1998; Mapelli et al., 2000; Ruyechan, 1983) and
interaction of single-stranded DNA with the ICP130 in nuclear
extracts obtained from EHV-1-infected cells (Lewis et al., 1995).
To further conﬁrm the binding speciﬁcity of the UL31P to the
single-stranded DNA, competition experiments were performed
using approximately 1-, 10-, and 100-fold molar excesses of
unlabeled competitors (Fig. 5D). The formation of the GST-
UL31P-IE(þ) DNA complex was inhibited in the presence of
increasing amounts of three single-stranded DNA competitors
IE(þ), IE(), and SV40E(þ), respectively (Fig. 5D, lanes 4–5,
7–8, and 12–14). However, the double-stranded DNA competitor
IE(þ/) did not inhibit the protein-DNA complexes in the
presence of increasing amounts of the competitor (Fig. 5D, lanes
9–11). These observations suggest that the UL31P has binding
speciﬁcity for a single-stranded DNA.UL31P harbors a nuclear localization signal in the extreme 32
residues of the C-terminus
Since the UL31P plays an essential role in viral DNA replication
and is a DNA-binding protein, it may harbor nuclear localization
signal sequences. To identify a sequence of the UL31P responsible
for nuclear localization, the plasmids of pGFP-UL31 encoding
different regions of the UL31 protein (Fig. 6A) were transfected
into RK13 cells, and the distribution of the green ﬂuorescent
protein (GFP) was determined under ﬂuorescence microscopy as
described in Materials and methods. The protein expression level
of all GFP-UL31 constructs was conﬁrmed by western blot using
an anti-rabbit polyclonal GFP antibody (Fig. 6B and D). As shown
in Fig. 6C, the full-length GFP–UL31P(1–1209) and GFP–
UL31P(601–1209) were localized in the nucleus, but the control
GFP was distributed in both cytoplasm and nucleus. GFP–
UL31P(1–600) and GFP–UL31P(301–900) were distributed in
cytoplasm, suggesting that the nuclear localization signal (NLS)
sequence is located within residues 601–1209 of the UL31P. The
UL31P(601–1209) was further dissected to identify the NLS
sequence (Fig. 6A). The GFP–UL31P(801–1209) and GFP–
UL31P(1001–1209) fusion proteins (Fig. 6C) as well as GFP–
UL31P(1101–1209) (Fig. 6E) were localized in the nucleus, indi-
cating that the NLS sequence of the UL31P is located within the
C-terminal 109 amino acid residues. To deﬁne the essential
sequences of UL31P NLS, N-terminal sequences of UL31P(1101–
1209) and C-terminal sequences of UL31P(801–1209) were
deleted as described in Materials and methods. The deletion of
C-terminal 9 and 34 residues of the UL31P(801–1209) resulted in
the failure of nuclear localization of the protein (Fig. 6E, 801–1200
and 801–1175), but only UL31P(801–1209) containing the intact
C-terminal sequence showed nuclear localization of GFP (Fig. 6C).
Furthermore, N-terminal sequence of the UL31P(1101–1209) was
deleted to determine the minimal NSL sequence required for its
nuclear localization. Deletion of N-terminal 71 and 77 amino acid
residues of the UL31P(1101–1209) [GFP–UL31P(1172–1209) and
GFP–UL31P(1178–1209)] did not affect the nuclear localization of
GFP–UL31P (Fig. 6E). However, deletion of the 83 and 89 amino
acid residues [GFP–UL31P(1184-1209) and GFP–UL31P(1190–
1209)] led to GFP distribution in both cytoplasm and nucleus
(Fig. 6E), indicating that the minimal NLS sequence of the UL31P
is located within the C-terminal 32 residues (aa 1178–1209).
To further determine the functional relevance of the NLS of
UL31P homologs, we compared the C-terminal 50 amino acid
residues of EHV-1 UL31 ORF harboring its NLS sequence with
those of UL31P homologs encoded by three other alphaherpes-
viruses. Multiple sequence alignment showed that the extreme
C-terminus of EHV-1 UL31P has approximately 42.6% and 44%
amino acid identity with that of HSV-1 ICP8 and PRV UL29,
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Fig. 5. Interaction of the UL31P with DNA. Gel shift and supershift assays were performed by using radiolabeled single- and double-stranded DNA probes, GST-UL31P
fusion protein, and anti-UL31P antibody YC3 as described in Materials and methods. (A) Western blot analysis of the puriﬁed GST-UL31 fusion protein with an anti-UL31
monoclonal antibody YC3. (B) Interaction of the UL31P with single-stranded DNA. The GST protein and puriﬁed GST-UL31P were mixed with 32P-labeled two single-
stranded DNA probes 46-mer EHV-1 IE (þ) oligonucleotide (positions 18 to 63 nt relative to the transcription start site, lanes 1–5) and its complementary
oligonucleotide (lanes 6–10), and 46-bp double-stranded IE(þ/) DNA (lanes 11–15) in the presence or absence of an anti-UL31 antibody YC3 and EHV-1 IE region
2-speciﬁc monoclonal antibody E1.1. The complexes supershifted with YC3 monoclonal antibody are indicated by arrowheads. (C) Gel shift assay using three different
sequence oligonucleotide probes. The GST-UL31P was mixed with radiolabeled 46-mer EHV-1 IE(þ) oligonucleotide (lanes 3 and 4), 60-mer EHV-1 TK promoter sequence
oligonucleotide (positions 290 to 349 nt relative to the translational start site of TK ORF, lanes 7 and 8), or 60-mer SV40 early promoter sequence oligonucleotide
(positions 10 to 69 nt relative to the transcription start site, lanes 11 and 12). The complexes supershifted with YC3 monoclonal antibody are indicated by arrowheads.
(D) Competition assay. The GST-UL31P was mixed with radiolabeled IE(þ) DNA in the presence or absence of increasing amounts of 46-mer IE(þ) oligonucleotide (lanes
3–5), 46-mer IE(–) oligonucleotide (lanes 6–8), 46-bp IE(þ/) double-stranded DNA (lanes 9–11), or 60-mer SV40E(þ) oligonucleotide competitor (lanes 12–14).
S. Kim et al. / Virology 432 (2012) 306–315310respectively, but exhibited only 10% homology with that of VZV
ORF29 that contains the NLS domain within its N-terminus
(Fig. 7). The minimal NLS sequence of the UL31P is similar to
that of HSV-1 ICP8.Discussion
The 78 genes of EHV-1 are regulated by EHV-1 regulatory
molecules (O’Callaghan and Osterrieder, 2008) at immediate-early,
early, and late stages (Caughman et al., 1985; Gray et al., 1987a).
After the expression of immediate-early and early genes, viral DNAreplication occurs followed by the expression of the late genes
(O’Callaghan and Osterrieder, 2008). Elucidating the functions of
replication-associated proteins is a key to understanding the
mechanisms of DNA replication and the pathogenesis of viral
diseases. There is little known about viral proteins associated
with EHV-1 replication except that ORF30P and ORF18P were
previously identiﬁed as a DNA polymerase and its accessory subunit,
respectively (Loregian et al., 2006). Considering the diverse role
of HSV-1 ICP8 and VZV ORF29P in the replication of HSV-1 and
VZV, respectively, it is still necessary to further characterize the
UL31 gene and the UL31P for a better understanding of EHV-1
replication.
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Fig. 6. Mapping of the nuclear localization signal (NLS) of EHV-1 UL31P. Construction of GFP-UL31 fusion genes and ﬂuorescence assays were performed as described in
Materials and methods. The numbers within UL31 parentheses indicate amino acid sequences of UL31P. (A) The schematic illustrates the amino acid sequence regions of
UL31P fused to the GFP and the subcellular localization of the GFP-UL31 fusion protein; N for nuclear, C for cytoplasmic, and C/N for both cytoplasmic and nuclear. (B and
D) Expression of GFP-UL31 fusion proteins. The GFP fusion proteins containing truncations of UL31 ORF were detected from whole-cell lysates of transfected RK13 cells at
24 h post transfection by using an anti-rabbit GFP antibody. Arrows, bands corresponding to GFP and GFP-UL31 fusion proteins. (C and E) Localization of GFP-UL31 fusion
proteins. Top, middle, and bottom panels indicate distribution of GFP-UL31 fusion protein, RK13 cell nucleus stained by DAPI, and merge of GFP and nucleus, respectively.
S. Kim et al. / Virology 432 (2012) 306–315 311Promoter assays indicated that the UL31 gene is trans-acti-
vated only by the IEP in synergistic fashion with the UL5P
(EICP27). In addition, detection of the UL31 RNA transcript and
the UL31P at the early stage of viral infection as well as metabolic
inhibition assays revealed that the UL31 gene, like the EHV-1
representative early gene TK, is an early gene. We also observed
that a consensus IEP-binding site (IEBS; 5’–ATCGT-3’) is located at
455-bp upstream of a tentative TATA box within the UL31
promoter region. This consensus IEBS may be a cis-acting elementrequired for IEP-mediated trans-activation of the UL31 gene
although we did not provide any evidence of the interaction of
the IEP with the IEBS sequence in this study.
Although previous studies (Lewis et al., 1995) reported that
the UL31P (previously designated ICP130) binds to both single-
and double-stranded DNAs in gel shift assays using EHV-1-
infected cell nuclear extract, sequence analysis of EHV-1 UL31P
showed a homology to single-stranded DNA-binding proteins,
such as HSV-1 ICP8 and VZV ORF29P that have multiple functions
Table 1
Primers used to construct UL31 promoter-luciferase reporter plasmids and full-length and truncated UL31 protein-expressing plasmids.
Plasmid Primer name (sequence [5’–3’])
pUL31(1423/3)-Luc UL31-F1 (ggctcgagaggtcctcttggttagttgc)
UL31-R4 (ccaagctttgtttacgaaactcggcccg)
pUL31(1423/143)-Luc UL31-F1/UL31-R3 (gggaagcttgttggcgggcagacttta)
pUL31(1423/265)-Luc UL31-F1/UL31-R2 (tttaagcttacagacatggcggcgcgcga)
pUL31(1033/143)-Luc UL31-F2 (ggctcgagtagtacagcgtcgtgtggca)/UL31-R3
pUL31(1033/3)-Luc UL31-F2/UL31-R4
pCMV-UL31 UL31ORF-F (ccgaattcgccaccatggagtctgcgcccaag)
UL31ORF-R (gtttgcggccgcttagagcatgtcaaaggtgagc)
pEGFP-N1SpeI SpeI-linker-F (tttgtacattactagttgctcagcccccaccagc)
SpeI-linker-R (gtttgcggccgctcaggttaataaagtttatggc)
pGFP–UL31P(1–1209) GFP-UL31-F1 (ttactagtatggagtctgcgcccaagacagtgag)/UL31ORF-R
pGFP–UL31P(1–600) GFP-UL31-F1/UL31P-600-R (gtttgcggccgcttacgtttccttgtcaatgagt)
pGFP–UL31P(601–1209) SpeI601-F (ttactagtctcgcgcaagccagcccc)/UL31ORF-R
pGFP–UL31P(301–900) SpeI301-F (ttactagtcaaggggatggcagcgga)
900-R (gtttgcggccgcttagaactgggccagctccccgat)
pGFP–UL31P(801–1209) SpeI801-F (ttactagtgccggcatggccagcgcctatcgcag)/UL31ORF-R
pGFP–UL31P(901–1209) SpeI901-F (ttactagttactttgccaacctggtgctcaaata)/UL31ORF-R
pGFP–UL31P(1001–1209) SpeI1001-F (ttactagtgtagacgacgagtttttggcggcgag)/UL31ORF-R
pGFP–UL31P(1101–1209) SpeI1101-F (ttactagtgcaggaaacaatcgcgtgtttcaggc)/UL31ORF-R
pGFP–UL31P(801–1200) SpeI801-F/1200-R (gtttgcggccgcttatttctccgggggggcaccc)
pGFP–UL31P(801–1175) SpeI801-F/1175-R (gtttgcggccgcttacatggccaggccaccgtta)
pGFP–UL31P(801–1150) SpeI801-F/1150-R (gtttgcggccgcttatccctcgccggcagctacc)
pGFP–UL31P(801–1125) SpeI801-F/1125-R (gtttgcggccgcttagctccactctccaaattga)
pGFP–UL31P(1202–1209) SpeI1202-F (ttactagttcggggctcacctttgacatgctc)
AﬂII-R (ttacgccttaagatacattgatgagtttggac)
pGFP–UL31P(1196–1209) SpeI1196-F (ttactagtgcccccccggagaaaaagtcgggg)/AﬂII-R
pGFP–UL31P(1190–1209) SpeI1190-F (ttactagtatcctgtttgacatgggtgccccc)/AﬂII-R
pGFP–UL31P(1184–1209) SpeI1184-F (ttactagtcggtccctaccggatgatatcctg)/AﬂII-R
pGFP–UL31P(1178–1209) SpeI1178-F (ttactagtgcccctgctggacaaaaacggtcc)/AﬂII-R
pGFP–UL31P(1172–1209) SpeI1172-F (ttactagtggcctggccatggcagctgcccct)/AﬂII-R
pGST-UL31 GEX-UL31-F (ttgaattcatggagtctgcgcccaagacagtgag)/UL31ORF-R
EHV-1 UL31
HSV-1 ICP8
PRV UL29
VZV ORF29
1160
1147
1126
1155
1209
Protein Amino acid sequence
1196
1175
1204
TVPTGPLGYVYACRVEDLDLEEISFLAARSTDSDLALLPLMRNLTVEKTFTSSLAVVSGAR
TTGLAGAGITLKLTTSHFYPSVFVFHGGKHVLPSSAAPNLTRACNAARERFGFSRCQGPP
VDGAVETTGAEICTRLGLEPENTIL - 154
VZV ORF29 NLS 9 -
- - - - - DTPQQSTSA FN-GGLAMAAAPAGQKRSLPDDILFDMGAPPEKKSGLTFDML
- - - - FGCEDDN ATPFG-GPGAPGPAFAGRKRAFHGDDPFGEG-PPDKKGDLTLDML
- - - - FGACGAGGDVAGLAPASLVPAELGGKRPPPEDDLFDMGAPPEKR - -LTFDML
AAPNLTRACNAARERFG- FSRCQGPPVDGAV ETTGA E ICTRLGLEPENT - - - - - - IL
Fig. 7. Alignment of the C-terminal 50 amino acids of EHV-1 UL31P with those of alphaherpesvirus homologs. The amino acid sequences of EHV-1 UL31 ORF and its
homologs were aligned by use of CLUSTALW2 multiple sequence alignment program (http://www.ebi.ac.uk/Tools/es/cgi-bin/clustalw2). EHV-1 UL31 (Ab4p strain,
GenBank ID: NC001491; RacL11 strain, Kim et al., unpublished data); HSV-1 ICP8 (GenBank ID: BAE78520); PRV UL29 (GenBank ID: NC006151); VZV ORF29 (GenBank ID:
ABW06912). The numbers indicate the amino acid position relative to the N-terminus for each UL31P homologs. The NLS sequences of EHV-1 UL31P and HSV-1 ICP8 are
underlined.
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et al., 2002; Reuven et al., 2003; Reuven and Weller, 2005;
Stallings et al., 2006). These observations imply that the certain
protein(s) in EHV-1-infected nuclear cell extract may be involved
in binding of the UL31P to the double-stranded DNA. To examine
this possibility, we employed puriﬁed GST–UL31P fusion protein
for gel shift assays. Similar to HSV-1 ICP8, which binds to a single-
stranded DNA (Gourves et al., 2000), the UL31P preferentially
bound to a single-stranded DNA in a sequence-independent
manner. This result supports that the UL31P is a single-stranded
DNA-binding protein, and also suggests that the binding of UL31P
to double-stranded DNA may be due to the additional viral and/or
cellular protein(s).
HSV-1 ICP8 and VZV ORF29P that harbor DNA-binding activity
are localized in the nucleus (Cohrs et al., 2002; Taylor and Knipe,
2003). It was also shown that the UL31P, a single-stranded DNA-
binding protein, is localized in the nucleus, suggesting that theUL31P harbors nuclear localization signal sequence. Dissection of
the UL31P fused to the GFP revealed that the essential NLS sequence
of UL31P is located at the C-terminus of the protein and the extreme
32 amino acid residues (aa 1178–1209) of UL31P is responsible for
its nuclear localization. According to previous results, HSV-1 ICP8,
like UL31P, harbors a NLS located in the C-terminal 28 amino acid
residues (Gao and Knipe, 1992), whereas VZV ORF29P contains
noncanonical NLS sequence located in amino acids 9–154 of
N-terminus (Stallings and Silverstein, 2005). Multiple sequence
alignments exhibited that ICP8 and UL31P share 52.6% overall amino
acid identity and 51.7% amino acid identity in the minimal NLS
domain, implying that the nuclear import mechanism of EHV-1
UL31P may be similar to that of HSV-1 ICP8.
Overall, characterization of the UL31P as a single-stranded
DNA protein suggests that UL31P may play an important role in
the DNA replicative complex. Considering multiple functions of
the single-stranded DNA-binding proteins of other herpes viruses,
S. Kim et al. / Virology 432 (2012) 306–315 313the UL31P may have additional role(s) in EHV-1 DNA replication.
Our ﬁndings such as the regulation of the early UL31 gene, NLS
localization of the UL31P, and a single-stranded DNA-binding
function of the UL31P would give an insight into further studies
for elucidating the mechanism of the UL31P in viral DNA
replication.Materials and methods
Cell and virus
Rabbit kidney RK13 cells were maintained with Eagle’s mini-
mal essential medium supplemented with 100 units/ml of peni-
cillin, 100 mg/ml of streptomycin, nonessential amino acids, and
5% fetal bovine serum. Pathogenic RacL11 was used as wild-
type EHV-1.Construction of the plasmids
PCR products were ampliﬁed using a pRacL11 EHV-1 BAC
template, Accuprime pfx polymerase (Invitrogen, Carlsbad, CA),
and appropriate primers (Table 1). PCR products were digested with
appropriate enzymes and cloned into the appropriate vector using
standard methods (Sambrook et al., 1989), and were conﬁrmed by
sequence analysis. Primer design was based on the published
sequences (Telford et al., 1992). The UL31 promoter regions were
PCR ampliﬁed as shown in Fig. 2A. PCR products of UL31(1423/
3), UL31(1423/143), UL31(1423/265), UL31(1033/
143), and UL31(1033/3) were digested with XhoI and HindIII,
and cloned into pGL3-Basic (Promega, Madison, WI) digested with
XhoI and HindIII [named pUL31(1423/3)-Luc, pUL31(1423/
143)-Luc, pUL31(1423/265)-Luc, pUL31(1033/143)-Luc,
and pUL31(1033/3)-Luc, respectively].
The UL31ORF PCR product was digested with EcoRI and NotI, and
cloned into pEGFP-N1 (BD Bioscience, San Jose, CA) digested with
EcoRI and NotI (named pCMV-UL31). To create a SpeI enzyme site
on pEGFP-N1 plasmid, the UL31(607–889) PCR product was
digested with BsrGI and NotI, and cloned into pEGFP-N1 (Clonetech,
Mountain View, CA) (named pEGFP-N1SpeI). To construct the GFP–
UL31 fusion gene containing different regions of the UL31 ORF, PCR
products of UL31(aa 1–1209), UL31(aa 1–600), UL31(aa 601–1209),
UL31(aa 301–900), UL31(aa 801–1209), UL31(aa 901–1209),
UL31(aa 1001–1209), UL31(aa 1101–1209), UL31(aa 801–1200),
UL31(aa 801–1175), UL31(aa 801–1150), and UL31(aa 801-1125)
were digested with SpeI and NotI, and cloned into pEGFP-N1SpeI
digested with SpeI and NotI [named pGFP–UL31P(1–1209),
pGFP–UL31P(1–600), pGFP–UL31P(601–1209), pGFP–UL31P(301–
900), pGFP–UL31P(801–1209), pGFP–UL31P(901–1209), pGFP–
UL31P(1001–1209), pGFP–UL31P(1101–1209), pGFP–UL31P
(801–1200), pGFP–UL31P(801–1175), pGFP–UL31P(801–1150), and
pGFP–UL31P(801–1125), respectively].
Next PCR ampliﬁcations were performed using a pGFP–
UL31P(1101–1209) as a template. PCR products of UL31(aa 1202–
1209), UL31(aa 1196–1209), UL31(aa 1190–1209), UL31(aa 1184–
1209), UL31(aa 1178–1209) and UL31(aa 1172–1209) were digested
with SpeI and AﬂII, and cloned into pEGFP-NSpeI digested with SpeI
and AﬂII [named pGFP–UL31P(1202–1209), pGFP–UL31P(1196–
1209), pGFP–UL31P(1190–1209), pGFP–UL31P(1184–1209), pGFP–
UL31P(1178–1209), and pGFP–UL31P(1172–1209), respectively]. To
construct GST–UL31 fusion protein, PCR product of UL31 ORF was
digested with EcoRI and NotI, and cloned into pGEX-4T-1 (GE
Healthcare, Piscataway, NJ) digested with EcoRI and NotI (named
pGST-UL31).Luciferase reporter assay
Promoter activity was examined as described in previous
studies (Kim et al., 2006). Brieﬂy, 70% conﬂuent RK13 cells were
prepared in 24-well plates and 0.1 pM of reporter vector and
0.3 pM of effector vector were used for cotransfection. Reporter
vectors were pUL31(1423/–3)-Luc, pUL31(–1423/–143)-Luc,
pUL31(–1423/–265)-Luc, pUL31(–1033/–143)-Luc, and pUL31
(–1033/–3)-Luc. The EHV-1 regulatory protein-expressing vectors
such as pSVIE, pSVIR2, pSVEICP0, pCMV–IR4 (EICP22), pSVUL5
(EICP27), and pCMV–ETIF (Ahn et al., 2007) as well as pCMV–
UL31 were used as effector vectors. 6 ml of lipofectin (Invitrogen)
was mixed with 300 ml of Opti-MEM medium (Gibco, BRL,
Gaithersburg, MD), and incubated for 45 min at room tempera-
ture. Reporter plasmid with or without effector plasmid(s) were
mixed with 300 ml of Opti-MEM medium (Gibco, BRL), and total
DNAs were adjusted to the same amount with the pSVSPORT1
DNA (Gibco, BRL). The mixture was combined and incubated at
room temperature for 15 min. One-third of the total mixture was
transferred into each of three wells of the RK13 cells. At 5 h post
transfection (hpt), normal growth medium was added, and
luciferase activities were measured at 48 hpt by using a luciferase
assay kit (Promega) and a POLARstar OPTIMA plate reader (BMG
LABTECH Inc., Burham, NC) according to the manufacturer’s
directions.
Western and northern blot analyses
90% conﬂuent RK13 cells were infected with EHV-1 at a
multiplicity of infection (moi) of 5 and transfected with pCMV–
UL31, pEGFP–UL31 or pEGFP-N1 plasmid using a Lipofectin
(Invitrogen) according to the manufacturer’s directions. After
24 h incubation, total cell extracts were prepared from virus-
infected or plasmid-transfected RK13 cells and applied to western
blot analyses. To determine the expression level of the UL31P at
indicated times post infection, RK13 cells were infected with
RacL11 at an moi of 5. Whole cell lysates were separated by a
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE), and then transferred to a nitrocellulose membrane
(Ambion, Austin, TX). The UL31P was detected by using an anti-
UL31P monoclonal antibody YC3 (a gift from Dr. Caughman,
Medical College of Georgia) as primary antibodies and an anti-
mouse IgG[Fc]-alkaline phosphatase conjugate (Promega) as
a secondary antibody. In addition, the GFP-UL31 fusion pro-
teins were detected with an anti-rabbit polyclonal GFP antibody
(Santa Cruz). Protein was visualized by incubating the membrane
containing blotted proteins in the AP conjugate substrate (AP
conjugate substrate kit, Bio-Rad Laboratories) according to
manufacturer’s directions.
To detect the UL31, gK, TK, and IE transcripts, total RNA was
isolated from mock- and virus-infected cells by using a RNeasy
Mini kit (Qiagen, Valencia, CA). Total RNA was separated on 3 or
5% denaturing acrylamide gel (8M Urea) and transferred to a
nylon membrane (Ambion) by using a semi-dry electroblotter
(Bio-Rad Laboratories). The PCR amplicons of UL31 gene (primers,
5’-ctc gcg caa gcc agc ccc tgc tca-3’/5’-gaa ctg ggc cag ctc ccc gat
gtt-3’), TK gene (primers, 5’-gcc ggt cag gcg gca agt aac aat agt tag-
3’/5’-gag ggt gct gct cat gag ggg tat tag aga-3’), gK gene (primers,
5’-tta gga cga gaa gga ctc gcc caa taa gcc-3’/5’-ctt atg ccg cgt tta
cca tct ggt ata ccc-3’), and IE gene (primers, 5’-ctc tac gac ttc atc
gag agc aac gac ttc-3’/5’-tcg ggc ctc tcc agc gtc ttg gcc aga ttg-3’)
were end-labeled with [g-32P]dATP (New England Nuclear Cor-
poration, Boston, MA) by T4 polynucleotide kinase (NEB, Beverly,
MA) according to the manufacturer’s directions, respectively. The
radiolabeled probe was denatured by adding a 1/10 vol of 3 M
NaOH for 10 min at room temperature and then neutralized by
adding an equal volume of 1 M Tris–HCl (pH 7). Prehybridization,
S. Kim et al. / Virology 432 (2012) 306–315314hybridization and washing were performed using the North-
ernMax Kit (Ambion) followed by autoradiography using a phos-
phor image screen and the molecular imager FX system (Bio-Rad
Laboratories).
Metabolic inhibition assays
Metabolic inhibition assays were performed using virus-
infected RK13 cells as previously described (Gray et al., 1987b;
Zhou et al., 1997). Brieﬂy, 85% conﬂuent RK13 cells were infected
with EHV-1 at an moi of 5 and incubated at 371C in the presence
or absence of the protein synthesis inhibitor cycloheximide (CHX,
100 mg/ml; Sigma-Aldrich Corp. St. Louis, MO) for 6 h, or in the
presence of the viral DNA replication inhibitor phosphonoacetic
acid (PAA, 200 mg/ml; Sigma-Aldrich Corp.) for 20 h followed by
total RNA isolation using a RNeasy Mini Kit (Qiagen, Valencia, CA).
Presence of RNA transcripts were determined by northern blot
assays using total RNA and probes speciﬁc to each of IE, UL31, gK
and TK RNA transcripts.
Gel shift assay
The DNA-binding assay and puriﬁcation of glutathione
S-transferase-UL31 fusion protein (GST-UL31P) were conducted
as previously described (Kim et al., 1995). A 46-mer DNA
oligonucleotide and its complement spanning the EHV-1 IE
promoter region (positions 18 to 63 nt relative to the tran-
scription start site, 5’-cca cta ggg gga agg caa aac tcc ctc gta gta
gta taa agc acc t-3’ and 5’-agg tgc ttt ata cta cga ggg agt ttt gcc ttc
ccc cta gtg g-3’), a 60-mer spanning EHV-1 thymidine kinase
promoter region (positions 290 to 349 nt relative to the
translational start site of TK ORF, 5’-tac tcg cgg tgt tca tat ttt tgg
aaa agc gac acg ttt tta gct cta tta gga tgc aca-3’), and a 60-mer
spanning SV40 early promoter (positions 10 to 69 nt relative
to the transcription start site, 5’-agt tcc gcc cat tct ccg ccc cat cgc
tga cta att ttt ttt att tat gca gag gcc gag-3’) were used in gel shift
assays. Each oligonucleotide and its complement were annealed
and either end-labeled with [g-32P]dATP (New England Nuclear
Corporation) and T4 polynucleotide kinase (Promega) according
to the manufacturer’s directions. The DNA-binding reactions were
carried out in a total volume of 20 ml containing approximately
1 ng of radiolabeled single- or double-stranded DNA probes
(2105 cpm/ng), 0.1 mg of poly(dI-dC) as a nonspeciﬁc compe-
titor, binding buffer (20 mM HEPES-KOH [pH 7.9], 0.5 mM dithio-
threitol, 10% glycerol, 0.1 mM EDTA, 0.025% NP-40, 25 mM KCl,
2 mM MgCl2), and 100 ng of indicated protein. The DNA binding
reaction mixtures were incubated at room temperature for
20 min. In the supershift assay, an anti-UL31P monoclonal anti-
body YC3 or EHV-1 IE region 2-speciﬁc monoclonal antibody E1.1
was added to the indicated reactions, and the reactions were
incubated for another 20 min at room temperature. For the
competition assay, 1-, 10-, 100-fold molar excess of unlabeled
DNA competitor were added to the binding reaction. After the
reaction, 5 ml of loading buffer (200 mM HEPES-KOH [pH 7.9], 50%
[vol/vol] glycerol, 0.02% bromphenol blue) was added, and the
reaction samples were separated by electrophoresis using a 3.5%
polyacrylamide gel with 0.5 Tris–borate–EDTA running buffer
and 2.5% glycerol [vol/vol] for 2.5 h at 200 V followed by auto-
radiography using a phosphor image screen and molecular imager
FX system (Bio-Rad Laboratories).
Direct ﬂuorescence microscopy
70% conﬂuent RK13 cells on cover slips were transfected with
GFP–UL31 fusion protein expressing plasmids or pEGFP-N1 con-
trol plasmid using a MATra A reagent (IBA Biotechnology, Goet-
tingen) according to manufacturer’s instructions. Brieﬂy, threemicrograms of plasmid DNA was diluted to 200 ml of complete
media (Mediatech, Inc., Manassas, VA) and mixed with 3 ml of
MATra A reagent, and the mixture was incubated at room
temperature for 20 min. Cells were washed with complete media
once, and one milliliter of complete media was added to DNA-
MATra A mixture. After the addition of 1.2 ml of the mixture to
each well, the plate was incubated on the magnet plate for
15 min. The mixtures were removed and replaced with 3 ml of
normal growth media followed by 24 h incubation at 37 1C in a
humidiﬁed CO2 incubator. The cells were washed twice with PBS
at 24 hpt, ﬁxed with 4% paraformaldehyde for 15 min at room
temperature, washed, and permeabilized with 0.2% Triton X-100
in PBS for 2 min followed by three PBS washes. Mounting solution
containing DAPI, Gold Antifade (Invitrogen), was applied to the
RK13 cells, and the location of GFP within the cell was examined
by a ﬂuorescence microscopy (Leica DMBI 6000 microscope).Acknowledgments
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